Helios Technologies Announces Transfer of Its Common Stock Listing to the New York Stock Exchange
Helios Technologies, Inc. (NYSE: HLIO) announced the transfer of its common stock listing from Nasdaq to the New York Stock Exchange (NYSE), effective November 1, 2021. This transition is expected to provide enhanced brand visibility and investor-relations services. The move is part of Helios's strategic growth plan, positioning it among leading companies. The listing transfer will be seamless for investors, requiring no action on their part. CEO Josef Matosevic highlighted the benefits of joining the NYSE, citing its unique market model and network of industry leaders.
- Transfer to NYSE expected to enhance brand visibility and investor relations.
- No action required from investors during the listing transition.
- Strategic move aligns with Helios's growth plans as a global electronics/hydraulics company.
- None.
Helios expects to commence trading on the NYSE at market open on
“We are pleased to join the NYSE, one of the world’s most prestigious trading platforms, as we continue to execute on our transformational journey as a pure play global electronics/hydraulics company,” said
“We are excited to welcome Helios as it transfers its listing to the NYSE,” said
About
Forward Looking Information
This news release contains “forward‐looking statements” within the meaning of Section 21E of the Securities Exchange Act of 1934. Forward‐looking statements involve risks and uncertainties, and actual results may differ materially from those expressed or implied by such statements. They include statements regarding current expectations, estimates, forecasts, projections, our beliefs, management’s plans, projections and objectives for future operations, scale and performance, integration plans and expected synergies therefrom, the timing of completion of the proposed transaction, and assumptions made by
Factors that could cause the actual results to differ materially from what is expressed or forecasted in such forward‐looking statements include, but are not limited to, (i) conditions in the capital markets, including the interest rate environment and the availability of capital; (ii) our failure to realize the benefits expected from the Balboa acquisition, our failure to promptly and effectively integrate the Balboa acquisition and the ability of Helios to retain and hire key personnel, and maintain relationships with suppliers (iii) risks related to health epidemics, pandemics and similar outbreaks and similar outbreaks, including, without limitation, the current COVID-19 pandemic, which may among other things, adversely affect our supply chain and material costs and have material adverse effects on our business, financial position, results of operations and/or cash flows; (iv) changes in the competitive marketplace that could affect the Company’s revenue and/or cost bases, such as increased competition, lack of qualified engineering, marketing, management or other personnel, and increased labor and raw materials costs; and (v) new product introductions, product sales mix and the geographic mix of sales nationally and internationally. Further information relating to factors that could cause actual results to differ from those anticipated is included but not limited to information under the heading Item 1. “Business” and Item 1A. “Risk Factors” in the Company’s Form 10-K for the year ended
View source version on businesswire.com: https://www.businesswire.com/news/home/20211019005207/en/
Vice President of Investor Relations, Corporate Communications and Risk Management
(941) 362-1333
tania.almond@HLIO.com
(716) 843-3908
dpawlowski@keiadvisors.com
Source:
FAQ
When will Helios Technologies start trading on the NYSE?
What is the ticker symbol for Helios Technologies on the NYSE?
Why is Helios Technologies transferring to the NYSE?